<p>擁有大量資金的鯨魚們對 <strong>強生</strong> 採取了明顯的看漲態度。</p>
<p>查看強生（紐約證券交易所代碼：JNJ）的期權歷史，我們發現了 11 筆交易。</p>
<p>如果考慮每筆交易的具體情況，可以準確地説，72% 的投資者以看漲的預期開倉，0% 以看跌的預期開倉。</p>
<p>在所有發現的交易中，有 4 筆是看跌期權，總金額為 411,540 美元，7 筆是看漲期權，總金額為 424,038 美元。</p>
<h3>價格目標是什麼？</h3>
<p>分析這些合約的成交量和未平倉合約，似乎大玩家在過去一個季度內關注強生的價格區間為 135.0 美元到 215.0 美元。</p>
<h3>成交量與未平倉合約的發展</h3>
<p>查看成交量和未平倉合約是交易期權時的一個強有力的舉措。這些數據可以幫助你跟蹤強生在特定行權價的期權流動性和興趣。下面，我們可以觀察到過去 30 天內，強生所有鯨魚交易的看漲和看跌期權的成交量和未平倉合約的演變，行權價範圍為 135.0 美元到 215.0 美元。</p>
<h3>強生 30 天期權成交量與興趣快照</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1766599293_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="期權看漲圖表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1766599293_0.png"/></p>
<h3>發現的重要期權交易：</h3>
<table>
<thead>
<tr>
<th><strong>代碼</strong></th>
<th><strong>看跌/看漲</strong></th>
<th><strong>交易類型</strong></th>
<th><strong>情緒</strong></th>
<th><strong>到期日</strong></th>
<th><strong>賣出價</strong></th>
<th><strong>買入價</strong></th>
<th><strong>價格</strong></th>
<th><strong>行權價</strong></th>
<th><strong>總交易價格</strong></th>
<th><strong>未平倉合約</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>看跌</td>
<td>掃描</td>
<td>看漲</td>
<td>01/16/26</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.55</td>
<td>$210.00</td>
<td>$222.0K</td>
<td>4.1K</td>
<td align="right">569</td>
</tr>
<tr>
<td>JNJ</td>
<td>看漲</td>
<td>交易</td>
<td>看漲</td>
<td>03/20/26</td>
<td>$29.85</td>
<td>$28.5</td>
<td>$29.44</td>
<td>$180.00</td>
<td>$147.2K</td>
<td>2.3K</td>
<td align="right">50</td>
</tr>
<tr>
<td>JNJ</td>
<td>看跌</td>
<td>掃描</td>
<td>看漲</td>
<td>01/15/27</td>
<td>$18.5</td>
<td>$17.3</td>
<td>$17.3</td>
<td>$210.00</td>
<td>$103.8K</td>
<td>119</td>
<td align="right">60</td>
</tr>
<tr>
<td>JNJ</td>
<td>看漲</td>
<td>交易</td>
<td>中性</td>
<td>01/15/27</td>
<td>$75.65</td>
<td>$72.7</td>
<td>$74.18</td>
<td>$135.00</td>
<td>$74.1K</td>
<td>363</td>
<td align="right">0</td>
</tr>
<tr>
<td>JNJ</td>
<td>看漲</td>
<td>掃描</td>
<td>看漲</td>
<td>01/02/26</td>
<td>$1.13</td>
<td>$1.04</td>
<td>$1.05</td>
<td>$210.00</td>
<td>$60.5K</td>
<td>469</td>
<td align="right">589</td>
</tr>
</tbody>
</table>
<h3>關於強生</h3>
<p>強生是全球最大的、最具多樣性的醫療保健公司。它有兩個部門：創新藥物和醫療技術。自 2023 年剝離消費業務 Kenvue 以來，這兩個部門現在代表了公司所有的銷售。在 2023-24 年的重組後，藥物部門專注於三個主要治療領域：免疫學、腫瘤學和神經學。從地域上看，超過一半的總收入來自美國。</p>
<p>在分析了與強生相關的期權活動後，我們轉向更仔細地觀察公司的自身表現。</p>
<h3>強生的當前狀況</h3>
<ul>
<li>當前交易量為 1,499,052，JNJ 的價格下跌了-0.07%，現為 205.64 美元。</li>
<li>RSI 讀數表明該股票目前在超買和超賣之間處於中性狀態。</li>
<li>預計收益發布將在 28 天內進行。</li>
</ul>
<h3>專家對強生的看法</h3>
<p>在過去 30 天內，共有 5 位專業分析師對該股票發表了看法，設定的平均價格目標為 223.8 美元。</p>
<p><strong>發現異常期權活動：聰明資金在行動</strong></p>
<p>Benzinga Edge 的異常期權板塊在潛在市場動向發生之前發現可能的市場推動者。查看大資金在你喜歡的股票上採取了什麼頭寸。點擊這裏訪問。
* RBC Capital 的一位分析師堅持對強生的跑贏大盤評級，維持目標價為 230 美元。
* B of A Securities 的一位分析師決定維持對強生的中性評級，目前的目標價為 220 美元。
* 摩根士丹利的一位分析師堅持對強生的等權評級，維持目標價為 197 美元。
* 高盛的一位分析師決定維持對強生的買入評級，目前的目標價為 240 美元。
* 花旗的一位分析師在評估中保持對強生的買入評級，目標價為 232 美元。</p>
<p>交易期權涉及更大的風險，但也提供了更高的利潤潛力。精明的交易者通過持續教育、戰略交易調整、利用各種指標以及關注市場動態來降低這些風險。通過 Benzinga Pro 跟蹤強生的最新期權交易，獲取實時警報。</p>

強生

<p>鯨魚們對強生持樂觀態度，72% 的期權交易顯示出積極情緒。分析師設定的平均目標價為 223.8 美元，評級範圍從中性到買入。顯著的期權交易包括在 135 美元到 215 美元的行權價範圍內的看漲和看跌期權。強生的股票目前處於中性狀態，交易價格為 205.64 美元，預計在 28 天內公佈財報。來自 RBC、美國銀行、摩根士丹利、高盛和花旗的分析師提供了不同的評級和目標價</p>

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Johnson &amp; Johnson</strong>.</p>
<div class="lb-trans"><p>擁有大量資金的鯨魚們對 <strong>強生</strong> 採取了明顯的看漲態度。</p>
</div><p>Looking at options history for Johnson &amp; Johnson (NYSE: JNJ) we detected 11 trades.</p>
<div class="lb-trans"><p>查看強生（紐約證券交易所代碼：JNJ）的期權歷史，我們發現了 11 筆交易。</p>
</div><p>If we consider the specifics of each trade, it is accurate to state that 72% of the investors opened trades with bullish expectations and 0% with bearish.</p>
<div class="lb-trans"><p>如果考慮每筆交易的具體情況，可以準確地説，72% 的投資者以看漲的預期開倉，0% 以看跌的預期開倉。</p>
</div><p>From the overall spotted trades, 4 are puts, for a total amount of $411,540 and 7, calls, for a total amount of $424,038.</p>
<div class="lb-trans"><p>在所有發現的交易中，有 4 筆是看跌期權，總金額為 411,540 美元，7 筆是看漲期權，總金額為 424,038 美元。</p>
</div><h3>What's The Price Target?</h3>
<div class="lb-trans"><h3>價格目標是什麼？</h3>
</div><p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $135.0 to $215.0 for Johnson &amp; Johnson during the past quarter.</p>
<div class="lb-trans"><p>分析這些合約的成交量和未平倉合約，似乎大玩家在過去一個季度內關注強生的價格區間為 135.0 美元到 215.0 美元。</p>
</div><h3>Volume &amp; Open Interest Development</h3>
<div class="lb-trans"><h3>成交量與未平倉合約的發展</h3>
</div><p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Johnson &amp; Johnson's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson &amp; Johnson's whale trades within a strike price range from $135.0 to $215.0 in the last 30 days.</p>
<div class="lb-trans"><p>查看成交量和未平倉合約是交易期權時的一個強有力的舉措。這些數據可以幫助你跟蹤強生在特定行權價的期權流動性和興趣。下面，我們可以觀察到過去 30 天內，強生所有鯨魚交易的看漲和看跌期權的成交量和未平倉合約的演變，行權價範圍為 135.0 美元到 215.0 美元。</p>
</div><h3>Johnson &amp; Johnson 30-Day Option Volume &amp; Interest Snapshot</h3>
<div class="lb-trans"><h3>強生 30 天期權成交量與興趣快照</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1766599293_0.png" alt="Options Call Chart" original-src="https://www.benzinga.com/files/images/story/2025/1766599293_0.png"/></p>
<h3>Significant Options Trades Detected:</h3>
<div class="lb-trans"><h3>發現的重要期權交易：</h3>
</div><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.55</td>
<td>$210.00</td>
<td>$222.0K</td>
<td>4.1K</td>
<td align="right">569</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$29.85</td>
<td>$28.5</td>
<td>$29.44</td>
<td>$180.00</td>
<td>$147.2K</td>
<td>2.3K</td>
<td align="right">50</td>
</tr>
<tr>
<td>JNJ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$18.5</td>
<td>$17.3</td>
<td>$17.3</td>
<td>$210.00</td>
<td>$103.8K</td>
<td>119</td>
<td align="right">60</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$75.65</td>
<td>$72.7</td>
<td>$74.18</td>
<td>$135.00</td>
<td>$74.1K</td>
<td>363</td>
<td align="right">0</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/02/26</td>
<td>$1.13</td>
<td>$1.04</td>
<td>$1.05</td>
<td>$210.00</td>
<td>$60.5K</td>
<td>469</td>
<td align="right">589</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>代碼</strong></th>
<th><strong>看跌/看漲</strong></th>
<th><strong>交易類型</strong></th>
<th><strong>情緒</strong></th>
<th><strong>到期日</strong></th>
<th><strong>賣出價</strong></th>
<th><strong>買入價</strong></th>
<th><strong>價格</strong></th>
<th><strong>行權價</strong></th>
<th><strong>總交易價格</strong></th>
<th><strong>未平倉合約</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>看跌</td>
<td>掃描</td>
<td>看漲</td>
<td>01/16/26</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.55</td>
<td>$210.00</td>
<td>$222.0K</td>
<td>4.1K</td>
<td align="right">569</td>
</tr>
<tr>
<td>JNJ</td>
<td>看漲</td>
<td>交易</td>
<td>看漲</td>
<td>03/20/26</td>
<td>$29.85</td>
<td>$28.5</td>
<td>$29.44</td>
<td>$180.00</td>
<td>$147.2K</td>
<td>2.3K</td>
<td align="right">50</td>
</tr>
<tr>
<td>JNJ</td>
<td>看跌</td>
<td>掃描</td>
<td>看漲</td>
<td>01/15/27</td>
<td>$18.5</td>
<td>$17.3</td>
<td>$17.3</td>
<td>$210.00</td>
<td>$103.8K</td>
<td>119</td>
<td align="right">60</td>
</tr>
<tr>
<td>JNJ</td>
<td>看漲</td>
<td>交易</td>
<td>中性</td>
<td>01/15/27</td>
<td>$75.65</td>
<td>$72.7</td>
<td>$74.18</td>
<td>$135.00</td>
<td>$74.1K</td>
<td>363</td>
<td align="right">0</td>
</tr>
<tr>
<td>JNJ</td>
<td>看漲</td>
<td>掃描</td>
<td>看漲</td>
<td>01/02/26</td>
<td>$1.13</td>
<td>$1.04</td>
<td>$1.05</td>
<td>$210.00</td>
<td>$60.5K</td>
<td>469</td>
<td align="right">589</td>
</tr>
</tbody>
</table>
</div><h3>About Johnson &amp; Johnson</h3>
<div class="lb-trans"><h3>關於強生</h3>
</div><p>Johnson &amp; Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.</p>
<div class="lb-trans"><p>強生是全球最大的、最具多樣性的醫療保健公司。它有兩個部門：創新藥物和醫療技術。自 2023 年剝離消費業務 Kenvue 以來，這兩個部門現在代表了公司所有的銷售。在 2023-24 年的重組後，藥物部門專注於三個主要治療領域：免疫學、腫瘤學和神經學。從地域上看，超過一半的總收入來自美國。</p>
</div><p>Following our analysis of the options activities associated with Johnson &amp; Johnson, we pivot to a closer look at the company's own performance.</p>
<div class="lb-trans"><p>在分析了與強生相關的期權活動後，我們轉向更仔細地觀察公司的自身表現。</p>
</div><h3>Current Position of Johnson &amp; Johnson</h3>
<div class="lb-trans"><h3>強生的當前狀況</h3>
</div><ul>
<li>Currently trading with a volume of 1,499,052, the JNJ's price is down by -0.07%, now at $205.64.</li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 28 days.</li>
</ul>
<div class="lb-trans"><ul>
<li>當前交易量為 1,499,052，JNJ 的價格下跌了-0.07%，現為 205.64 美元。</li>
<li>RSI 讀數表明該股票目前在超買和超賣之間處於中性狀態。</li>
<li>預計收益發布將在 28 天內進行。</li>
</ul>
</div><h3>What The Experts Say On Johnson &amp; Johnson</h3>
<div class="lb-trans"><h3>專家對強生的看法</h3>
</div><p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $223.8.</p>
<div class="lb-trans"><p>在過去 30 天內，共有 5 位專業分析師對該股票發表了看法，設定的平均價格目標為 223.8 美元。</p>
</div><p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<div class="lb-trans"><p><strong>發現異常期權活動：聰明資金在行動</strong></p>
</div><p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* An analyst from RBC Capital persists with their Outperform rating on Johnson &amp; Johnson, maintaining a target price of $230.
* An analyst from B of A Securities has decided to maintain their Neutral rating on Johnson &amp; Johnson, which currently sits at a price target of $220.
* An analyst from Morgan Stanley persists with their Equal-Weight rating on Johnson &amp; Johnson, maintaining a target price of $197.
* An analyst from Goldman Sachs has decided to maintain their Buy rating on Johnson &amp; Johnson, which currently sits at a price target of $240.
* Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Johnson &amp; Johnson with a target price of $232.</p>
<div class="lb-trans"><p>Benzinga Edge 的異常期權板塊在潛在市場動向發生之前發現可能的市場推動者。查看大資金在你喜歡的股票上採取了什麼頭寸。點擊這裏訪問。
* RBC Capital 的一位分析師堅持對強生的跑贏大盤評級，維持目標價為 230 美元。
* B of A Securities 的一位分析師決定維持對強生的中性評級，目前的目標價為 220 美元。
* 摩根士丹利的一位分析師堅持對強生的等權評級，維持目標價為 197 美元。
* 高盛的一位分析師決定維持對強生的買入評級，目前的目標價為 240 美元。
* 花旗的一位分析師在評估中保持對強生的買入評級，目標價為 232 美元。</p>
</div><p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Johnson &amp; Johnson with Benzinga Pro for real-time alerts.</p>
<div class="lb-trans"><p>交易期權涉及更大的風險，但也提供了更高的利潤潛力。精明的交易者通過持續教育、戰略交易調整、利用各種指標以及關注市場動態來降低這些風險。通過 Benzinga Pro 跟蹤強生的最新期權交易，獲取實時警報。</p>
</div>

強生的選擇：深入瞭解大資金的想法